Clinical Trials Browser

Phase 1/2 × ixazomib × 90 days × Clear all

NCT03547700 2026-05-06

Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)

Phase 1/2 Terminated

11 enrolled 10 charts

Lymphoma, T-Cell, Peripheral

NCT02343042 2026-05-04

STOMP

Phase 1/2 Active not recruiting

Multiple Myeloma, Recurrence